Correction (DOI:10.1016/j.jaci.2006.03.037);The genetics of atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 118, Issue 1, 2006, Pages 24-34

  Morar, Nilesh ^a,b   Willis Owen, Saffron A G ^b   Moffatt, Miriam F ^b   Cookson, William O C M ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Atopic dermatitis; candidate gene; genetics; linkage; microarray

Indexed keywords

CALCINEURIN INHIBITOR; CERAMIDE; CHEMOKINE; CHEMOKINE RECEPTOR ANTAGONIST; CHYMASE; CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; EOTAXIN; FC RECEPTOR; FC RECEPTOR BETA CHAIN; IMMUNOSUPPRESSIVE AGENT; MAST CELL CHYMASE 1; PLANT HOMOLOGY DOMAIN FINGER PROTEIN 11; PROTEIN; RANTES; RECEPTOR SUBUNIT; RECOMBINANT GAMMA INTERFERON; STEROID; TACROLIMUS; UNCLASSIFIED DRUG;

ATOPIC DERMATITIS; ATOPY; AUTOIMMUNE DISEASE; CROHN DISEASE; DISEASE TRANSMISSION; DNA MICROARRAY; ENTERITIS; ENVIRONMENTAL FACTOR; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC LINKAGE; GENETIC SCREENING; GENETIC VARIABILITY; GENOMICS; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HUMIDIFIER; IMMUNOMODULATION; INFLAMMATORY DISEASE; LEPROSY; MATERNAL DISEASE; MOLECULAR GENETICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN DISEASE; SKIN FUNCTION; SKIN INFLAMMATION;

EID: 33745428678     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.07.042     Document Type: Erratum

References (128)

1. Wise F., and Sulzberger M. Footnote on problems of eczema, neurodermatitis and lichenification (1993), Year Book Publishers, Chicago
2. Larsen F.S., Holm N.V., and Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 15 (1986) 487-494
3. Schultz Larsen F. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 28 (1993) 719-723
4. Taylor B., Wadsworth J., Wadsworth M., and Peckham C. Changes in the reported prevalence of childhood eczema since the 1939-45 war. Lancet 2 (1984) 1255-1257
5. Schultz-Larsen F., and Hanifin J. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 22 (2002) 1-24
6. Cox H.E., Moffatt M.F., Faux J.A., Walley A.J., Coleman R., Trembath R.C., et al. Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor. Br J Dermatol 138 (1998) 182-187
7. Luoma R., Koivikko A., and Viander M. Development of asthma, allergic rhinitis and atopic dermatitis by the age of five years. A prospective study of 543 newborns. Allergy 38 (1983) 339-346
8. Dold S., Wjst M., von Mutius E., Reitmeir P., and Stiepel E. Genetic risk for asthma, allergic rhinitis, and atopic dermatitis. Arch Dis Child 67 (1992) 1018-1022
9. Wadonda-Kabondo N., Sterne J.A., Golding J., Kennedy C.T., Archer C.B., and Dunnill M.G. Association of parental eczema, hayfever, and asthma with atopic dermatitis in infancy: birth cohort study. Arch Dis Child 89 (2004) 917-921
10. Hanifin J.M., and Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 92 (1980) 44-47
11. Williams H.C., Burney P.G., Pembroke A.C., and Hay R.J. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 131 (1994) 406-416
12. Palmer L.J., Burton P.R., Faux J.A., James A.L., Musk A.W., and Cookson W.O. Independent inheritance of serum immunoglobulin E concentrations and airway responsiveness. Am J Respir Crit Care Med 161 (2000) 1836-1843
13. Johansson S.G., Bieber T., Dahl R., Friedmann P.S., Lanier B.Q., Lockey R.F., et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113 (2004) 832-836
14. Cox H. Clinical and genetic aspects of atopic dermatitis (1999), University of London, London
15. Jeong C.W., Ahn K.S., Rho N.K., Park Y.D., Lee D.Y., Lee J.H., et al. Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs. extrinsic atopic dermatitis patients using semiquantitative RT-PCR. Clin Exp Allergy 33 (2003) 1717-1724
16. Rho N.K., Kim W.S., Lee D.Y., Lee J.H., Lee E.S., and Yang J.M. Immunophenotyping of inflammatory cells in lesional skin of the extrinsic and intrinsic types of atopic dermatitis. Br J Dermatol 151 (2004) 119-125
17. Oppel T., Schuller E., Gunther S., Moderer M., Haberstok J., Bieber T., et al. Phenotyping of epidermal dendritic cells allows the differentiation between extrinsic and intrinsic forms of atopic dermatitis. Br J Dermatol 143 (2000) 1193-1198
18. Flohr C., Johansson S.G., Wahlgren C.F., and Williams H. How atopic is atopic dermatitis?. J Allergy Clin Immunol 114 (2004) 150-158
19. Ruiz R.G., Kemeny D.M., and Price J.F. Higher risk of infantile atopic dermatitis from maternal atopy than from paternal atopy. Clin Exp Allergy 22 (1992) 762-766
20. Diepgen T.L., and Blettner M. Analysis of familial aggregation of atopic eczema and other atopic diseases by ODDS RATIO regression models. J Invest Dermatol 106 (1996) 977-981
21. Purvis D.J., Thompson J.M., Clark P.M., Robinson E., Black P.N., Wild C.J., et al. Risk factors for atopic dermatitis in New Zealand children at 3.5 years of age. Br J Dermatol 152 (2005) 742-749
22. Cookson W.O., Young R.P., Sandford A.J., Moffatt M.F., Shirakawa T., Sharp P.A., et al. Maternal inheritance of atopic IgE responsiveness on chromosome 11q. Lancet 340 (1992) 381-384
23. Lee Y.A., Wahn U., Kehrt R., Tarani L., Businco L., Gustafsson D., et al. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet 26 (2000) 470-473
24. Walley A.J., Chavanas S., Moffatt M.F., Esnouf R.M., Ubhi B., Lawrence R., et al. Gene polymorphism in Netherton and common atopic disease. Nat Genet 29 (2001) 175-178
25. Cookson W.O., Ubhi B., Lawrence R., Abecasis G.R., Walley A.J., Cox H.E., et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 27 (2001) 372-373
26. Bradley M., Soderhall C., Luthman H., Wahlgren C.F., Kockum I., and Nordenskjold M. Susceptibility loci for atopic dermatitis on chromosomes 3, 13, 15, 17 and 18 in a Swedish population. Hum Mol Genet 11 (2002) 1539-1548
27. Haagerup A., Bjerke T., Schiotz P.O., Dahl R., Binderup H.G., Tan Q., et al. Atopic dermatitis-a total genome-scan for susceptibility genes. Acta Derm Venereol 84 (2004) 346-352
28. Zhang Y., Leaves N.I., Anderson G.G., Ponting C.P., Broxholme J., Holt R., et al. Positional cloning of a quantitative trait locus on chromosome 13q14 that influences immunoglobulin E levels and asthma. Nat Genet 34 (2003) 181-186
29. Williams H., Robertson C., Stewart A., Ait-Khaled N., Anabwani G., Anderson R., et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 103 (1999) 125-138
30. Darvasi A., Weinreb A., Minke V., Weller J.I., and Soller M. Detecting marker-QTL linkage and estimating QTL gene effect and map location using a saturated genetic map. Genetics 134 (1993) 943-951
31. Lander E., and Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11 (1995) 241-247
32. Beyer K., Nickel R., Freidhoff L., Bjorksten B., Huang S.K., Barnes K.C., et al. Association and linkage of atopic dermatitis with chromosome 13q12-14 and 5q31-33 markers. J Invest Dermatol 115 (2000) 906-908
33. Soderhall C., Bradley M., Kockum I., Wahlgren C.F., Luthman H., and Nordenskjold M. Linkage and association to candidate regions in Swedish atopic dermatitis families. Hum Genet 109 (2001) 129-135
34. Mao X.Q., Shirakawa T., Yoshikawa T., Yoshikawa K., Kawai M., Sasaki S., et al. Association between genetic variants of mast-cell chymase and eczema. Lancet 348 (1996) 581-583
35. Mao X.Q., Shirakawa T., Enomoto T., Shimazu S., Dake Y., Kitano H., et al. Association between variants of mast cell chymase gene and serum IgE levels in eczema. Hum Hered 48 (1998) 38-41
36. Weidinger S., Rummler L., Klopp N., Wagenpfeil S., Baurecht H.J., Fischer G., et al. Association study of mast cell chymase polymorphisms with atopy. Allergy 60 (2005) 1256-1261
37. Nickel R.G., Casolaro V., Wahn U., Beyer K., Barnes K.C., Plunkett B.S., et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 164 (2000) 1612-1616
38. Tsunemi Y., Saeki H., Nakamura K., Sekiya T., Hirai K., Fujita H., et al. Eotaxin gene single nucleotide polymorphisms in the promoter and exon regions are not associated with susceptibility to atopic dermatitis, but two of them in the promoter region are associated with serum IgE levels in patients with atopic dermatitis. J Dermatol Sci 29 (2002) 222-228
39. Jang N., Stewart G., and Jones G. Polymorphisms within the PHF11 gene at chromosome 13q14 are associated with childhood atopic dermatitis. Genes Immun 6 (2005) 262-264
40. Kawashima T., Noguchi E., Arinami T., Yamakawa-Kobayashi K., Nakagawa H., Otsuka F., et al. Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med Genet 35 (1998) 502-504
41. Liu X., Nickel R., Beyer K., Wahn U., Ehrlich E., Freidhoff L.R., et al. An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J Allergy Clin Immunol 106 (2000) 167-170
42. Tsunemi Y., Saeki H., Nakamura K., Sekiya T., Hirai K., Kakinuma T., et al. Interleukin-13 gene polymorphism G4257A is associated with atopic dermatitis in Japanese patients. J Dermatol Sci 30 (2002) 100-107
43. Chae S.C., Song J.H., Lee Y.C., Kim J.W., and Chung H.T. The association of the exon 4 variations of Tim-1 gene with allergic diseases in a Korean population. Biochem Biophys Res Commun 312 (2003) 346-350
44. Kato A., Fukai K., Oiso N., Hosomi N., Murakami T., and Ishii M. Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br J Dermatol 148 (2003) 665-669
45. Nishio Y., Noguchi E., Shibasaki M., Kamioka M., Ichikawa E., Ichikawa K., et al. Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese. Genes Immun 4 (2003) 515-517
46. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38 (2006) 441-446
47. Kabesch M., Peters W., Carr D., Leupold W., Weiland S.K., and von Mutius E. Association between polymorphisms in caspase recruitment domain containing protein 15 and allergy in two German populations. J Allergy Clin Immunol 111 (2003) 813-817
48. Jones G., Wu S., Jang N., Fulcher D., Hogan P., and Stewart G. Polymorphisms within the CTLA4 gene are associated with infant atopic dermatitis. Br J Dermatol 154 (2006) 467-471
49. Moffatt MF AM, Reynolds NJ, Meggitt ST, Cookson WO, Barker JN. A case-control study investigating candidate genes in adult eczema. Presented at: 35th Annual European Society of Dermatological Research Meeting. Tubingen (Germany): Blackwell; 2005. p. A22.
50. Ahmad-Nejad P., Mrabet-Dahbi S., Breuer K., Klotz M., Werfel T., Herz U., et al. The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 113 (2004) 565-567
51. Nishio Y., Noguchi E., Ito S., Ichikawa E., Umebayashi Y., Otsuka F., et al. Mutation and association analysis of the interferon regulatory factor 2 gene (IRF2) with atopic dermatitis. J Hum Genet 46 (2001) 664-667
52. Lange J., Heinzmann A., Zehle C., and Kopp M. CT genotype of promotor polymorphism C159T in the CD14 gene is associated with lower prevalence of atopic dermatitis and lower IL-13 production. Pediatr Allergy Immunol 16 (2005) 456-457
53. Rafatpanah H., Bennett E., Pravica V., McCoy M.J., David T.J., Hutchinson I.V., et al. Association between novel GM-CSF gene polymorphisms and the frequency and severity of atopic dermatitis. J Allergy Clin Immunol 112 (2003) 593-598
54. Moffatt M.F., Sharp P.A., Faux J.A., Young R.P., Cookson W.O., and Hopkin J.M. Factors confounding genetic linkage between atopy and chromosome 11q. Clin Exp Allergy 22 (1992) 1046-1051
55. Novak N., Kruse S., Potreck J., Maintz L., Jenneck C., Weidinger S., et al. Single nucleotide polymorphisms of the IL18 gene are associated with atopic eczema. J Allergy Clin Immunol 115 (2005) 828-833
56. Tanaka K., Sugiura H., Uehara M., Sato H., Hashimoto-Tamaoki T., and Furuyama J. Association between mast cell chymase genotype and atopic eczema: comparison between patients with atopic eczema alone and those with atopic eczema and atopic respiratory disease. Clin Exp Allergy 29 (1999) 800-803
57. Iwanaga T., McEuen A., Walls A.F., Clough J.B., Keith T.P., Rorke S., et al. Polymorphism of the mast cell chymase gene (CMA1) promoter region: lack of association with asthma but association with serum total immunoglobulin E levels in adult atopic dermatitis. Clin Exp Allergy 34 (2004) 1037-1042
58. Oiso N., Fukai K., and Ishii M. Interleukin 4 receptor alpha chain polymorphism Gln551Arg is associated with adult atopic dermatitis in Japan. Br J Dermatol 142 (2000) 1003-1006
59. Hosomi N., Fukai K., Oiso N., Kato A., Ishii M., Kunimoto H., et al. Polymorphisms in the promoter of the interleukin-4 receptor alpha chain gene are associated with atopic dermatitis in Japan. J Invest Dermatol 122 (2004) 843-845
60. Arkwright P.D., Chase J.M., Babbage S., Pravica V., David T.J., and Hutchinson I.V. Atopic dermatitis is associated with a low-producer transforming growth factor beta(1) cytokine genotype. J Allergy Clin Immunol 108 (2001) 281-284
61. Vasilopoulos Y., Cork M.J., Murphy R., Williams H.C., Robinson D.A., Duff G.W., et al. Genetic association between an AACC insertion in the 3′UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol 123 (2004) 62-66
62. Vavilin V.A., Safronova O.G., Lyapunova A.A., Lyakhovich V.V., Kaznacheeva L.F., Manankin N.A., et al. Interaction of GSTM1, GSTT1, and GSTP1 genotypes in determination of predisposition to atopic dermatitis. Bull Exp Biol Med 136 (2003) 388-391
63. Cookson W.O., Sharp P.A., Faux J.A., and Hopkin J.M. Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 1 (1989) 1292-1295
64. Young R.P., Sharp P.A., Lynch J.R., Faux J.A., Lathrop G.M., Cookson W.O., et al. Confirmation of genetic linkage between atopic IgE responses and chromosome 11q13. J Med Genet 29 (1992) 236-238
65. Hill M.R., and Cookson W.O. A new variant of the beta subunit of the high-affinity receptor for immunoglobulin E (Fc epsilon RI-beta E237G): associations with measures of atopy and bronchial hyper-responsiveness. Hum Mol Genet 5 (1996) 959-962
66. Hill M.R., James A.L., Faux J.A., Ryan G., Hopkin J.M., le Souef P., et al. Fc epsilon RI-beta polymorphism and risk of atopy in a general population sample. BMJ 311 (1995) 776-779
67. Lin S., Cicala C., Scharenberg A.M., and Kinet J.P. The Fc(epsilon)RIbeta subunit functions as an amplifier of Fc(epsilon)RIgamma-mediated cell activation signals. Cell 85 (1996) 985-995
68. On M., Billingsley J.M., Jouvin M.H., and Kinet J.P. Molecular dissection of the FcRbeta signaling amplifier. J Biol Chem 279 (2004) 45782-45790
69. Andrasfalvy M., Peterfy H., Toth G., Matko J., Abramson J., Kerekes K., et al. The beta subunit of the type I Fcepsilon receptor is a target for peptides inhibiting IgE-mediated secretory response of mast cells. J Immunol 175 (2005) 2801-2806
70. Traherne J.A., Hill M.R., Hysi P., D'Amato M., Broxholme J., Mott R., et al. LD mapping of maternally and non-maternally derived alleles and atopy in FcepsilonRI-beta. Hum Mol Genet 12 (2003) 2577-2585
71. He S., and Walls A.F. The induction of a prolonged increase in microvascular permeability by human mast cell chymase. Eur J Pharmacol 352 (1998) 91-98
72. He S., and Walls A.F. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo. Br J Pharmacol 125 (1998) 1491-1500
73. Saarinen J., Kalkkinen N., Welgus H.G., and Kovanen P.T. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J Biol Chem 269 (1994) 18134-18140
74. Kofford M.W., Schwartz L.B., Schechter N.M., Yager D.R., Diegelmann R.F., and Graham M.F. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide. J Biol Chem 272 (1997) 7127-7131
75. Taipale J., Lohi J., Saarinen J., Kovanen P.T., and Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem 270 (1995) 4689-4696
76. Badertscher K., Bronnimann M., Karlen S., Braathen L.R., and Yawalkar N. Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis. Arch Dermatol Res 296 (2005) 503-506
77. Pascale E., Tarani L., Meglio P., Businco L., Battiloro E., Cimino-Reale G., et al. Absence of association between a variant of the mast cell chymase gene and atopic dermatitis in an Italian population. Hum Hered 51 (2001) 177-179
78. Kawashima T., Noguchi E., Arinami T., Kobayashi K., Otsuka F., and Hamaguchi H. No evidence for an association between a variant of the mast cell chymase gene and atopic dermatitis based on case-control and haplotype-relative-risk analyses. Hum Hered 48 (1998) 271-274
79. Alam R. Chemokines in allergic inflammation. J Allergy Clin Immunol 99 (1997) 273-277
80. Ponath P.D., Qin S., Ringler D.J., Clark-Lewis I., Wang J., Kassam N., et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 97 (1996) 604-612
81. Cheng S.S., Lukacs N.W., and Kunkel S.L. Eotaxin/CCL11 is a negative regulator of neutrophil recruitment in a murine model of endotoxemia. Exp Mol Pathol 73 (2002) 1-8
82. Cheng S.S., Lukacs N.W., and Kunkel S.L. Eotaxin/CCL11 suppresses IL-8/CXCL8 secretion from human dermal microvascular endothelial cells. J Immunol 168 (2002) 2887-2894
83. Kaburagi Y., Shimada Y., Nagaoka T., Hasegawa M., Takehara K., and Sato S. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 293 (2001) 350-355
84. Yawalkar N., Uguccioni M., Scharer J., Braunwalder J., Karlen S., Dewald B., et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 113 (1999) 43-48
85. Park C.W., Lee B.H., Han H.J., Lee C.H., and Ahn H.K. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis. Br J Dermatol 152 (2005) 1173-1181
86. Arakawa S., Hatano Y., Katagiri K., Terashi H., and Fujiwara S. Effects of ultraviolet B irradiation on the production of regulated upon activation normal T-cell expressed and secreted protein in cultured human epidermal keratinocytes. Arch Dermatol Res 297 (2006) 377-380
87. Bai B., Tanaka K., Tazawa T., Yamamoto N., and Sugiura H. Association between RANTES promoter polymorphism -401A and enhanced RANTES production in atopic dermatitis patients. J Dermatol Sci 39 (2005) 189-191
88. Kozma G.T., Falus A., Bojszko A., Krikovszky D., Szabo T., Nagy A., et al. Lack of association between atopic eczema/dermatitis syndrome and polymorphisms in the promoter region of RANTES and regulatory region of MCP-1. Allergy 57 (2002) 160-163
89. Suzuki K., Morokata T., Morihira K., Sato I., Takizawa S., Kaneko M., et al. In vitro and in vivo characterization of a novel CCR3 antagonist, YM-344031. Biochem Biophys Res Commun 339 (2006) 1217-1223
90. Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H., Jongeneel V., et al. Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer 83 (1999) 456-464
91. Marsh D.G., Neely J.D., Breazeale D.R., Ghosh B., Freidhoff L.R., Ehrlich-Kautzky E., et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264 (1994) 1152-1156
92. Forrest S., Dunn K., Elliott K., Fitzpatrick E., Fullerton J., McCarthy M., et al. Identifying genes predisposing to atopic eczema. J Allergy Clin Immunol 104 (1999) 1066-1070
93. Laouini D., Kawamoto S., Yalcindag A., Bryce P., Mizoguchi E., Oettgen H., et al. Epicutaneous sensitization with superantigen induces allergic skin inflammation. J Allergy Clin Immunol 112 (2003) 981-987
94. He J.Q., Chan-Yeung M., Becker A.B., Dimich-Ward H., Ferguson A.C., Manfreda J., et al. Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children. Genes Immun 4 (2003) 385-389
95. Jongepier H., Koppelman G.H., Nolte I.M., Bruinenberg M., Bleecker E.R., Meyers D.A., et al. Polymorphisms in SPINK5 are not associated with asthma in a Dutch population. J Allergy Clin Immunol 115 (2005) 486-492
96. Folster-Holst R., Stoll M., Koch W.A., Hampe J., Christophers E., and Schreiber S. Lack of association of SPINK5 polymorphisms with nonsyndromic atopic dermatitis in the population of Northern Germany. Br J Dermatol 152 (2005) 1365-1367
97. Tazawa T., Sugiura H., Sugiura Y., and Uehara M. Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis. Arch Dermatol Res 295 (2004) 459-464
98. Komatsu N., Takata M., Otsuki N., Ohka R., Amano O., Takehara K., et al. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J Invest Dermatol 118 (2002) 436-443
99. Egelrud T., Brattsand M., Kreutzmann P., Walden M., Vitzithum K., Marx U.C., et al. hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6. Br J Dermatol 153 (2005) 1200-1203
100. Sugiura H., Ebise H., Tazawa T., Tanaka K., Sugiura Y., Uehara M., et al. Large-scale DNA microarray analysis of atopic skin lesions shows overexpression of an epidermal differentiation gene cluster in the alternative pathway and lack of protective gene expression in the cornified envelope. Br J Dermatol 152 (2005) 146-149
101. Seguchi T., Cui C.Y., Kusuda S., Takahashi M., Aisu K., and Tezuka T. Decreased expression of filaggrin in atopic skin. Arch Dermatol Res 288 (1996) 442-446
102. Smith F.J., Irvine A.D., Terron-Kwiatkowski A., Sandilands A., Campbell L.E., Zhao Y., et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 38 (2006) 337-342
103. Zondervan K.T., and Cardon L.R. The complex interplay among factors that influence allelic association. Nat Rev Genet 5 (2004) 89-100
104. Lettice L.A., Horikoshi T., Heaney S.J., van Baren M.J., van der Linde H.C., Breedveld G.J., et al. Disruption of a long-range cis-acting regulator for Shh causes preaxial polydactyly. Proc Natl Acad Sci U S A 99 (2002) 7548-7553
105. Nomura I., Gao B., Boguniewicz M., Darst M.A., Travers J.B., and Leung D.Y. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 112 (2003) 1195-1202
106. Ogawa K., Ito M., Takeuchi K., Nakada A., Heishi M., Suto H., et al. Tenascin-C is upregulated in the skin lesions of patients with atopic dermatitis. J Dermatol Sci 40 (2005) 35-41
107. de Jongh G.J., Zeeuwen P.L., Kucharekova M., Pfundt R., van der Valk P.G., Blokx W., et al. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 125 (2005) 1163-1173
108. Heishi M., Kagaya S., Katsunuma T., Nakajima T., Yuki K., Akasawa A., et al. High-density oligonucleotide array analysis of mRNA transcripts in peripheral blood cells of severe atopic dermatitis patients. Int Arch Allergy Immunol 129 (2002) 57-66
109. Hijnen D., Nijhuis E., Bruin-Weller M., Holstege F., Koerkamp M.G., Kok I., et al. Differential expression of genes involved in skin homing, proliferation, and apoptosis in CD4+ T cells of patients with atopic dermatitis. J Invest Dermatol 125 (2005) 1149-1155
110. Matsumoto Y., Oshida T., Obayashi I., Imai Y., Matsui K., Yoshida N.L., et al. Identification of highly expressed genes in peripheral blood T cells from patients with atopic dermatitis. Int Arch Allergy Immunol 129 (2002) 327-340
111. Ogawa K., Hashida R., Miyagawa M., Kagaya S., Sugita Y., Matsumoto K., et al. Analysis of gene expression in peripheral blood eosinophils from patients with atopic dermatitis and in vitro cytokine-stimulated blood eosinophils. Clin Exp Immunol 131 (2003) 436-445
112. Nagata N., Oshida T., Yoshida N.L., Yuyama N., Sugita Y., Tsujimoto G., et al. Analysis of highly expressed genes in monocytes from atopic dermatitis patients. Int Arch Allergy Immunol 132 (2003) 156-167
113. Williams H.C. Epidemiology of atopic dermatitis. Clin Exp Dermatol 25 (2000) 522-529
114. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
115. Weidinger S., Klopp N., Rummler L., Wagenpfeil S., Baurecht H.J., Gauger A., et al. Association of CARD15 polymorphisms with atopy-related traits in a population-based cohort of Caucasian adults. Clin Exp Allergy 35 (2005) 866-872
116. Weidinger S., Klopp N., Rummler L., Wagenpfeil S., Novak N., Baurecht H.J., et al. Association of NOD1 polymorphisms with atopic eczema and related phenotypes. J Allergy Clin Immunol 116 (2005) 177-184
117. Laitinen T., Daly M.J., Rioux J.D., Kauppi P., Laprise C., Petays T., et al. A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population. Nat Genet 28 (2001) 87-91
118. Tosh K., Meisner S., Siddiqui M.R., Balakrishnan K., Ghei S., Golding M., et al. A region of chromosome 20 is linked to leprosy susceptibility in a South Indian population. J Infect Dis 186 (2002) 1190-1193
119. Gaffney P.M., Ortmann W.A., Selby S.A., Shark K.B., Ockenden T.C., Rohlf K.E., et al. Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am J Hum Genet 66 (2000) 547-556
120. Bowcock A.M., and Cookson W.O. The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum Mol Genet 13 (2004) R43-R55
121. Rieg S., Steffen H., Seeber S., Humeny A., Kalbacher H., Dietz K., et al. Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol 174 (2005) 8003-8010
122. Lane J.E., Cheyney J.M., Lane T.N., Kent D.E., and Cohen D.J. Treatment of recalcitrant atopic dermatitis with omalizumab. J Am Acad Dermatol 54 (2006) 68-72
123. Chamlin S.L., Kao J., Frieden I.J., Sheu M.Y., Fowler A.J., Fluhr J.W., et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 47 (2002) 198-208
124. Kootiratrakarn T., Fujimura T., Sano K., Okuyama R., Aiba S., Tagami H., et al. Development of a novel Ag-specific immunotherapy using CpG oligodeoxynucleotides in a new, unique mouse cutaneous eosinophilic inflammation model. Eur J Immunol 35 (2005) 3277-3286
125. Hanifin J.M., Schneider L.C., Leung D.Y., Ellis C.N., Jaffe H.S., Izu A.E., et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 28 (1993) 189-197
126. Imada T., Komorita N., Kobayashi F., Naito K., Yoshikawa T., Miyazaki M., et al. Therapeutic potential of a specific chymase inhibitor in atopic dermatitis. Jpn J Pharmacol 90 (2002) 214-217
127. Watanabe N., Tomimori Y., Saito K., Miura K., Wada A., Tsudzuki M., et al. Chymase inhibitor improves dermatitis in NC/Nga mice. Int Arch Allergy Immunol 128 (2002) 229-234
128. Wachter A.M., and Lezdey J. Treatment of atopic dermatitis with alpha 1-proteinase inhibitor. Ann Allergy 69 (1992) 407-414